Brief: Alembic Pharmaceuticals March-Quarter Consol Profit 2.03 Billion Rupees
15/05/2026 10:17
May 15 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS: ALEMBIC PHARMACEUTICALS LTD - DECLARES DIVIDEND OF 12 RUPEES PER SHARE ALEMBIC PHARMACEUTICALS LTD MARCH-QUARTER CONSOL PROFIT 2.03 BILLION RUPEES ALEMBIC PHARMACEUTICALS LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 18.48 BILLION RUPEES Source text: [ID:] Further company coverage: ALEM.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand